Literature DB >> 6120324

High plasma concentrations of beta-receptor blocking drugs and deficient debrisoquine hydroxylation.

G Alvan, C von Bahr, P Seidemann, F Sjöqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6120324     DOI： 10.1016/s0140-6736(82)91583-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  30 in total

1.  Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.

Authors:  R V Lewis; L E Ramsay; P R Jackson; W W Yeo; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 2.  Drug-related lupus. Incidence, mechanisms and clinical implications.

Authors:  L E Adams; E V Hess
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

Review 3.  Ethnic differences in drug disposition and responsiveness.

Authors:  A J Wood; H H Zhou
Journal:  Clin Pharmacokinet       Date:  1991-05       Impact factor: 6.447

4.  Prevalence of debrisoquine oxidation phenotypes in glaucoma patients.

Authors:  L Salminen; R Lindberg; H R Toivari; R Huupponen; T Kaila; E Iisalo
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

5.  Prevalence of drug hydroxylator phenotypes in Belgium.

Authors:  V Leclercq; J P Desager; Y van Nieuwenhuyze; C Harvengt
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Contribution of the genetic status of oxidative metabolism to variability in the plasma concentrations of beta-adrenoceptor blocking agents.

Authors:  P Dayer; L Balant; A Küpfer; F Courvoisier; J Fabre
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 7.  Beta adrenoceptor antagonists after myocardial infarction--where are we now?

Authors:  D A Chamberlain
Journal:  Br Heart J       Date:  1983-02

8.  Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.

Authors:  E L Carey; H J Duff; D M Roden; R K Primm; G R Wilkinson; T Wang; J A Oates; R L Woosley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

9.  Desipramine pharmacokinetics in Chinese and Caucasian volunteers.

Authors:  M V Rudorfer; E A Lane; W H Chang; M D Zhang; W Z Potter
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

10.  Polymorphic metabolism of beta-adrenoceptor antagonists.

Authors:  J H Silas; M S Lennard; G T Tucker; L E Ramsay; H F Woods
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.